An investigation on behalf of investors in OvaScience Inc (NASDAQ:OVAS) shares over potential wrongdoing at OvaScience Inc was announced and NASDAQ:OVAS stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 02/24/2017 -- Certain directors of OvaScience Inc are under investigation over potential wrongdoing. The investigation was announced for investors in shares of OvaScience Inc (NASDAQ:OVAS) over potential breaches of fiduciary duties by certain directors at OvaScience.
Investors who purchased shares of OvaScience Inc (NASDAQ:OVAS) have certain options and should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
The investigation by a law firm concerns whether certain OvaScience officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Waltham, MA based OvaScience, Inc. is a global fertility company that is focused on the discovery, development and commercialization of fertility treatment options for women.
Shares of OvaScience Inc (NASDAQ:OVAS) declined from as high as $50.18 per share in January 2015 to as low as $1.34 per share in December 2016.
On February 23, 2017, NASDAQ:OVAS shares closed at $1.45 per share.
Those who purchased shares of OvaScience Inc have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego